Cablegate: Belgium: Review for Phase 3 Study of Ptc124 In

VZCZCXYZ0000
RR RUEHWEB

DE RUEHBS #1676 3491157
ZNR UUUUU ZZH
R 151157Z DEC 09
FM AMEMBASSY BRUSSELS
TO RUEAUSA/HHS WASHDC
RUEHC/SECSTATE WASHDC 9808

UNCLAS BRUSSELS 001676

SIPDIS

HHS FOR FDA OFFICE OF INTERNATIONAL PROGRAMS: DAVID P.
KELLEY

E.O. 12958: N/A
TAGS: ABUD AFIN BR KSCA OSCI TBIO US
SUBJECT: BELGIUM: REVIEW FOR PHASE 3 STUDY OF PTC124 IN
CYSTIC FIBROSIS - NO FOREIGN POLICY OBJECTIONS

REF: STATE 121848

1. (U) Post has determined that there are no concerns or
objections regarding foreign policy implications in the
awarding of this research grant with any of the four
participating institutions in Belgium.

GUTMAN
.

© Scoop Media